相关实验视频

Updated: Jan 15, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

高4E-BP1的表达与染色体8的增加和CDK4/6敏感性在尤文肉瘤中相关

Cornelius M Funk^1,2,3, Anna C Ehlers^1,2,3, Martin F Orth⁴

¹German Cancer Research Center (DKFZ) Heidelberg, Division of Translational Pediatric Sarcoma Research, Heidelberg, Germany.

The Journal of clinical investigation

|October 16, 2025

概括

尤文肉瘤的8号染色体增加与生存率低下有关,主要是通过增加4E-BP1表达. 这一发现提供了新的预后生物标志物和潜在的治疗点,包括CDK4/6抑制剂.

科学领域:

在瘤学瘤学.
癌症基因组学癌症基因组学
分子生物学分子生物学

背景情况:

染色体8 (chr8) 增加在癌症中很常见,但它们在瘤异质性中的作用未得到充分研究.
尤文肉瘤 (EwS) 具有很少的复发突变,使得chr8增长成为临床多样性的关键因素.
在EwS中,chr8增益是第二个最常见的变化,为研究chr8的影响提供了一个模型.

研究的目的:

探索 chr8 增长对 EwS 瘤异质性的贡献.
为了识别chr8编码的基因驱动EWS的不良预后.
研究4E-BP1在EWS中的功能作用及其治疗影响.

主要方法:

在EWS中,Chr8增长与患者生存率和基因表达的相关性分析.
多基因分析分析以了解4E-BP1的分子网络.
在体外和体外功能研究通过沉默4E-BP1.1.
药物查以评估对CDK4/6抑制剂的敏感性.

主要成果:

chr8增益驱动的表达模式与EWS患者的整体存活率差相关.
增加EIF4EBP1 (编码为4E-BP1) 的表达与chr8的增加和生存率低下密切相关.
4E-BP1沉默降低了扩散和瘤生长;高的4E-BP1表达使EWS对CDK4/6抑制剂敏感.
在其他癌症类型中观察到类似的chr8增益和4E-BP1与生存的关联.

结论:

chr8的增加和4E-BP1的升高是EWS的预后生物标志物.
4E-BP1推动了促成扩散的网络,导致了糟糕的结果.
针对4E-BP1或使用CDK4/6抑制剂可能是EWS与chr8增益的有效疗法.

关键词:

癌症癌症癌症癌症遗传变异是一种遗传变异.遗传学是一个遗传学.鼠标模型鼠标模型在瘤学瘤学.

更多相关视频

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...